Skip to main content

Find Clinical Trials

Home
Conditions
Mechanistic Effects of SGLT2 Inhibition and/ or MR Antagonism on Body Fluid and Electrolyte Homeostatis

Clinical trial condition

Mechanistic Effects of SGLT2 Inhibition and/ or MR Antagonism on Body Fluid and Electrolyte Homeostatis

Explore clinical trials studying Mechanistic Effects of SGLT2 Inhibition and/ or MR Antagonism on Body Fluid and Electrolyte Homeostatis. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Mechanistic Effects of SGLT2 Inhibition and/ or MR Antagonism on Body Fluid and Electrolyte Homeostatis trial results

Completed

A Study to Investigate the Mechanistic Effects of Dapagliflozin Alone or in Combination With Balcinrenone, Compared to Balcinrenone and Placebo on Body Fluid and Electrolyte Handling and Energy Metabolism in Participants Over 50 Years of Age With Chronic Kidney Disease.

NCT05884866

Conditions: Chronic Disease, Chronic Kidney Disease Stage 3, Chronic Renal Failure, +14 more
Locations: Assistance Publique-Hopitaux de Marseille (AP-HM) Marseille, France

Klinikum Nuernberg Nuremberg, Bavaria, Germany

View Trial Details